Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

6 results about "Cannabinol" patented technology

Cannabinol (CBN) is a mildly psychoactive cannabinoid found only in trace amounts in Cannabis, and is mostly found in aged Cannabis. Pharmacologically relevant quantities are formed as a metabolite of tetrahydrocannabinol (THC). CBN acts as a partial agonist at the CB₁ receptors, but has a higher affinity to CB₂ receptors; however, it has lower affinities relative to THC. Degraded or oxidized cannabis products, such as low-quality baled cannabis and traditionally produced hashish, are high in CBN.

Decarboxylated cannabis compositions and methods of making the same

Decarboxylated cannabis compositions and methods of making and using the same are provided. The methods produce a decarboxylated product that has more terpenes and cannabidiol preserved and less oxidation of tetrahydrocannabinol to cannabinol, compared to a decarboxylated product made by a traditional decarboxylation process.
Owner:LEVINE ALEXANDER JOHN +1

Methods and compositions for substituted axially-chiral cannabinol analogs

In one aspect, the disclosure relates to substituted axially-chiral cannabinol analogs, methods of making same, pharmaceutical compositions comprising same, and methods of treating pain using same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Owner:UNIV OF FLORIDA RESEARCH FOUNDATION INC

Oral pharmaceutical formulations of cannabidiol and tetrahydrocannabinol

The present invention relates to a modified-release solid oral pharmaceutical composition, which is in the form of an enteric-coated capsule, wherein said capsule comprises cannabidiol (CBD), tetrahydrocannabinol (THC) and an emulsifier, and wherein the capsule optionally further comprises one or more cannabis terpenes. The solid oral pharmaceutical composition provided herein has a particularly advantageous modified release profile as well as an improved oral bioavailability as compared to conventional formulations of CBD and THC.
Owner:LUKAS HEIL-BETRIEBSSTÄTTE GMBH

THC (tetrahydrocannabinol) destroying method and system based on photocatalytic oxidation

PendingCN121571448ASolid waste disposalPtru catalystReactive oxygen radicals
The invention relates to a method for destroying tetrahydrocannabinol (THC), in particular to a method and a system for destroying tetrahydrocannabinol based on photocatalytic oxidation. According to the invention, nano titanium dioxide (TiO2) is used as a catalyst, active oxygen free radicals are generated under the excitation of ultraviolet rays with specific wavelength, and the THC molecular structure is decomposed. The multi-stage reaction system is adopted, raw material pretreatment, solvent dissolution and dispersion, photocatalytic degradation reaction and tail gas purification modules are integrated, tetrahydrocannabinol is decomposed on a production line, the supervision pressure in production is relieved, the degradation rate of tetrahydrocannabinol reaches 99% or above, degradation products are carbon dioxide, water and trace inert organic acid, and high efficiency and environment friendliness are achieved. The method is suitable for innocent treatment of hemp processing waste, law enforcement inspection products or medical waste, and is simple to operate, high in practicability and suitable for industrial popularization and application.
Owner:YUNNAN LVXIN BIOLOGICAL PHARMA CO LTD

Methods and compositions for substituted axially-chiral cannabinol analogs

In one aspect, the disclosure relates to substituted axially-chiral cannabinol analogs, methods of making same, pharmaceutical compositions comprising same, and methods of treating pain using same. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
Owner:UNIV OF FLORIDA RESEARCH FOUNDATION INC